Real-world brain volumetry in multiple sclerosis: importance of methodological consistency and clinical relevance of gray matter atrophy

Using automated brain volumetry with post-acquisition harmonization to address scanner variability, we did not detect accelerated BVL in this real-world MS cohort compared to healthy individuals. Nonetheless, GM volume loss was found to be clinically relevant in MS.